FDA.reportPublic FDA data

pemigatinib 13.5 MG Oral Tablet [Pemazyre]

RxCUI
2359340
RxNorm name
pemigatinib 13.5 MG Oral Tablet [Pemazyre]
Display name
pemigatinib 13.5 MG Oral Tablet [Pemazyre]
Full name
pemigatinib 13.5 MG Oral Tablet [Pemazyre]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
9e1f2222-1d89-4e63-989c-ccebe2ab1eb4pemigatinib 13.5 MG Oral Tablet [Pemazyre]SBD15These highlights do not include all the information needed to use PEMAZYRE safely and effectively. See full prescribing information for PEMAZYRE . PEMAZYRE® (pemigatinib) tablets, for oral use Initial U.S. Approval: 202020230614
9e1f2222-1d89-4e63-989c-ccebe2ab1eb4Pemazyre 13.5 MG Oral TabletSY15These highlights do not include all the information needed to use PEMAZYRE safely and effectively. See full prescribing information for PEMAZYRE . PEMAZYRE® (pemigatinib) tablets, for oral use Initial U.S. Approval: 202020230614
9e1f2222-1d89-4e63-989c-ccebe2ab1eb4Pemazyre 13.5 MG Oral TabletPSN15These highlights do not include all the information needed to use PEMAZYRE safely and effectively. See full prescribing information for PEMAZYRE . PEMAZYRE® (pemigatinib) tablets, for oral use Initial U.S. Approval: 202020230614